Association between body mass index and pancreatitis in children with acute lymphoblastic leukemia
- 18 April 2018
- journal article
- editorial
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 65 (8) , e27071
Abstract
No abstract availableFunding Information
- Børnecancerfonden
- Kræftens Bekæmpelse
- Dansk Kræftforsknings Fond
- Københavns Universitet
- Det Sundhedsvidenskabelige Fakultet, Københavns Universitet
This publication has 10 references indexed in Scilit:
- Predictors of hepatotoxicity and pancreatitis in children and adolescents with acute lymphoblastic leukemia treated according to contemporary regimensPediatric Blood & Cancer, 2017
- Asparaginase-associated pancreatitis in childhood acute lymphoblastic leukaemia: an observational Ponte di Legno Toxicity Working Group studyThe Lancet Oncology, 2017
- Acute PancreatitisNew England Journal of Medicine, 2016
- Asparaginase‐associated pancreatitis is not predicted by hypertriglyceridemia or pancreatic enzyme levels in children with acute lymphoblastic leukemiaPediatric Blood & Cancer, 2016
- Asparaginase-associated pancreatitis: a study on phenotype and genotype in the NOPHO ALL2008 protocolLeukemia, 2016
- Limitations of body mass index to assess body composition due to sarcopenic obesity during leukemia therapyLeukemia & Lymphoma, 2015
- Toxicity profile and treatment delays in NOPHO ALL2008—comparing adults and children with Philadelphia chromosome‐negative acute lymphoblastic leukemiaEuropean Journal of Haematology, 2015
- Defining obesity risk status in the general childhood population: Which cut-offs should we use?Pediatric Obesity, 2010
- Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01Blood, 2001
- Body mass index of 0 to 45-y-old Danes: reference values and comparison with published European reference valuesInternational Journal of Obesity, 2001